These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 8265633)

  • 1. Metabolic correction and cross-correction of mucopolysaccharidosis type II (Hunter syndrome) by retroviral-mediated gene transfer and expression of human iduronate-2-sulfatase.
    Braun SE; Aronovich EL; Anderson RA; Crotty PL; McIvor RS; Whitley CB
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11830-4. PubMed ID: 8265633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical studies of lymphocyte gene therapy for mild Hunter syndrome (mucopolysaccharidosis type II).
    Braun SE; Pan D; Aronovich EL; Jonsson JJ; McIvor RS; Whitley CB
    Hum Gene Ther; 1996 Feb; 7(3):283-90. PubMed ID: 8835216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Supercharged Cells" for delivery of recombinant human iduronate-2-sulfatase.
    Pan D; Jonsson JJ; Braun SE; McIvor RS; Whitley CB
    Mol Genet Metab; 2000 Jul; 70(3):170-8. PubMed ID: 10924271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of Neurocognitive Deficiency in Mucopolysaccharidosis Type II Mice by Central Nervous System-Directed, AAV9-Mediated Iduronate Sulfatase Gene Transfer.
    Laoharawee K; Podetz-Pedersen KM; Nguyen TT; Evenstar LB; Kitto KF; Nan Z; Fairbanks CA; Low WC; Kozarsky KF; McIvor RS
    Hum Gene Ther; 2017 Aug; 28(8):626-638. PubMed ID: 28478695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined ultrafiltration-transduction in a hollow-fiber bioreactor facilitates retrovirus-mediated gene transfer into peripheral blood lymphocytes from patients with mucopolysaccharidosis type II.
    Pan D; Shankar R; Stroncek DF; Whitley CB
    Hum Gene Ther; 1999 Nov; 10(17):2799-810. PubMed ID: 10584926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroviral-mediated transfer of the iduronate-2-sulfatase gene into lymphocytes for treatment of mild Hunter syndrome (mucopolysaccharidosis type II).
    Whitley CB; McIvor RS; Aronovich EL; Berry SA; Blazar BR; Burger SR; Kersey JH; King RA; Faras AJ; Latchaw RE; McCullough J; Pan D; Ramsay NK; Stroncek DF
    Hum Gene Ther; 1996 Mar; 7(4):537-49. PubMed ID: 8800749
    [No Abstract]   [Full Text] [Related]  

  • 7. Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA.
    Wilson PJ; Morris CP; Anson DS; Occhiodoro T; Bielicki J; Clements PR; Hopwood JJ
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8531-5. PubMed ID: 2122463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro correction of iduronate-2-sulfatase deficiency by adenovirus-mediated gene transfer.
    Di Francesco C; Cracco C; Tomanin R; Picci L; Ventura L; Zacchello E; Di Natale P; Anson DS; Hopwood JJ; Graham FL; Scarpa M
    Gene Ther; 1997 May; 4(5):442-8. PubMed ID: 9274721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a novel mucopolysaccharidosis type II mouse model and recombinant AAV2/8 vector-mediated gene therapy.
    Jung SC; Park ES; Choi EN; Kim CH; Kim SJ; Jin DK
    Mol Cells; 2010 Jul; 30(1):13-8. PubMed ID: 20652491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation analysis of the iduronate-2-sulfatase gene in patients with mucopolysaccharidosis type II (Hunter syndrome).
    Bunge S; Steglich C; Beck M; Rosenkranz W; Schwinger E; Hopwood JJ; Gal A
    Hum Mol Genet; 1992 Aug; 1(5):335-9. PubMed ID: 1303211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arylsulfatase B activities and glycosaminoglycan levels in retrovirally transduced mucopolysaccharidosis type VI cells. Prospects for gene therapy.
    Fillat C; Simonaro CM; Yeyati PL; Abkowitz JL; Haskins ME; Schuchman EH
    J Clin Invest; 1996 Jul; 98(2):497-502. PubMed ID: 8755662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retroviral transduction and expansion of peripheral blood lymphocytes for the treatment of mucopolysaccharidosis type II, Hunter's syndrome.
    Stroncek DF; Hubel A; Shankar RA; Burger SR; Pan D; McCullough J; Whitley CB
    Transfusion; 1999 Apr; 39(4):343-50. PubMed ID: 10220258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics and Gene Therapy in Hunter Disease.
    Sestito S; Falvo F; Scozzafava C; Apa R; Pensabene L; Bonapace G; Moricca MT; Concolino D
    Curr Gene Ther; 2018; 18(2):90-95. PubMed ID: 29618310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of an alternative transcript from the human iduronate-2-sulfatase (IDS) gene.
    Malmgren H; Carlberg BM; Pettersson U; Bondeson ML
    Genomics; 1995 Sep; 29(1):291-3. PubMed ID: 8530090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idursulfase enzyme replacement therapy in an adult patient with severe Hunter syndrome having a novel mutation of iduronate-2-sulfatase gene.
    Christianto A; Watanabe H; Nakajima T; Inazu T
    Clin Chim Acta; 2013 Aug; 423():66-8. PubMed ID: 23726270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation R468W of the iduronate-2-sulfatase gene in mild Hunter syndrome (mucopolysaccharidosis type II) confirmed by in vitro mutagenesis and expression.
    Crotty PL; Braun SE; Anderson RA; Whitley CB
    Hum Mol Genet; 1992 Dec; 1(9):755-7. PubMed ID: 1284597
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of iduronate-2-sulfatase mRNA expression in Hunter syndrome (mucopolysaccharidosis type II).
    Crotty PL; Whitley CB
    Hum Genet; 1992 Nov; 90(3):285-8. PubMed ID: 1283150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of a high efficiency retroviral vector for gene therapy of Hunter's syndrome.
    Hong Y; Yu SS; Kim JM; Lee K; Na YS; Whitley CB; Sugimoto Y; Kim S
    J Gene Med; 2003 Jan; 5(1):18-29. PubMed ID: 12516048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic Correction of Murine Mucopolysaccharidosis Type II by Engraftment of
    Smith MC; Belur LR; Karlen AD; Erlanson O; Podetz-Pedersen KM; McKenzie J; Detellis J; Gagnidze K; Parsons G; Robinson N; Labarre S; Shah S; Furcich J; Lund TC; Tsai HC; McIvor RS; Bonner M
    Hum Gene Ther; 2022 Dec; 33(23-24):1279-1292. PubMed ID: 36226412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the organisation of coding sequences within the iduronate sulphate sulphatase (IDS) gene.
    Flomen RH; Green EP; Green PM; Bentley DR; Giannelli F
    Hum Mol Genet; 1993 Jan; 2(1):5-10. PubMed ID: 8490623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.